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Abstract: Enzymes are essential components of biological reactions and play important roles in the
scaling and optimization of many industrial processes. Due to the growing commercial demand
for new and more efficient enzymes to help further optimize these processes, many studies are
now focusing their attention on more renewable and environmentally sustainable sources for the
production of these enzymes. Microalgae are very promising from this perspective since they can
be cultivated in photobioreactors, allowing the production of high biomass levels in a cost-efficient
manner. This is reflected in the increased number of publications in this area, especially in the use of
microalgae as a source of novel enzymes. In particular, various microalgal enzymes with different
industrial applications (e.g., lipids and biofuel production, healthcare, and bioremediation) have
been studied to date, and the modification of enzymatic sequences involved in lipid and carotenoid
production has resulted in promising results. However, the entire biosynthetic pathways/systems
leading to synthesis of potentially important bioactive compounds have in many cases yet to be
fully characterized (e.g., for the synthesis of polyketides). Nonetheless, with recent advances in
microalgal genomics and transcriptomic approaches, it is becoming easier to identify sequences
encoding targeted enzymes, increasing the likelihood of the identification, heterologous expression,
and characterization of these enzymes of interest. This review provides an overview of the state of
the art in marine and freshwater microalgal enzymes with potential biotechnological applications
and provides future perspectives for this field.
Keywords: microalgae; enzymes; marine biotechnology; -omics technologies; heterologous
expression; homologous expression
1. Introduction
Water covers around 71% of the Earth’s surface, with salt water responsible for 96.5% of this
percentage [1]. Due to its molecular structure and chemical properties, water includes (and often
participates in) every chemical reaction that is biologically relevant [2]. In such reactions, enzymes
cover a fundamental role: They are organic macromolecules that catalyze biological reactions (so-called
“biocatalysts” [3]). Due to their substrate-specificity, enzymes are commonly used in several sectors
(such as food processing, detergent, pharmaceuticals, biofuel, and paper production) to improve, scale,
and optimize industrial production. For example, hydrolases, which are enzymes that catalyze the
hydrolysis of chemical bonds, have applications in several fields. Examples of industrially relevant
hydrolases are cellulases for biofuel production [4], amylases for syrup production [5], papain, phytases
and galactosidases for food processing [6], and other hydrolases which have various pharmaceutical
applications [7]. The demand for new enzymes is growing every year, and many financial reports
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expect the global enzyme market value to surpass the $10 billion mark by 2024 (Allied Market
Research, 2018, https://www.alliedmarketresearch.com/enzymes-market;ResearchandMarket.com,
2018, https://www.researchandmarkets.com/research/6zpvw9/industrial?w=4), of which $7 billion
alone will be for industrial applications (BCC Research, 2018, https://www.bccresearch.com/market-
research/biotechnology/global-markets-for-enzymes-in-industrial-applications.html).
Microalgae are photosynthetic unicellular organisms that can be massively cultivated
under controlled conditions in photobioreactors with relatively small quantities of micro- and
macro-nutrients [8], and can thus fit perfectly into this market sector. Microalgae continue to
be used in a number of biotechnological applications. Searching the available literature in the PubMed
database, this trend is clearly visible (search filters used were the word “microalgae” in the Title/Abstract
field and the word “biotechnolog*” in the Text Word field, using the asterisk wildcard to expand the
term selection; Figure 1). Considering the full 20-year interval between “1999–2018”, it is clear that as
of 2012, there has been a rapid increase in the number of publications involving both “microalgae” and
“biotechnology”, reaching a peak in the years 2015–2016.
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Figure 1. Microalgae Biotechnology PubMed Search Results 1999–2018. Using PubMed datab se search
in the 20-years interval 1999–2018, the following search filter were set: The word “microalgae” in
the [Title/Abstract] field and the word “biotechnolog*” in the [Text Word] field, using the asterisk (*)
wildcard to expand the term selection (suc as biot chnology, biotechnological, and biotechnologies).
The literature regarding the biotechnological applications of microalgae is dominated by four
main research sectors: (1) Direct use of microalg l cells, for bioremediation applications and as food
supplements [9]; (2) Extraction of bioactives f r different applications (e.g., cosmeceutical, utraceutical,
and pharmaceutical applications, and for biofuel production [10,11]); (3) Use of microalgae as
platforms for heterologous expression or endogenous gene editing and overexpression [12]; (4) Use of
microalgae as sources of enzymes for industrial applications [13]. The latter field appears to be less
well-studied compared to the others, due to the high costs currently involved in enzyme extraction
and characterization, as well as the scarcity of annotated microalgal genomes.
Recent projects, such as those funded under the European Union Seventh Framework 2007–2017
(EU FP-7), e.g., BIOFAT (https://cordis.europa.eu/project/rcn/100477/factsheet/en) and GIAVAP
(https://cordis.europa.eu/project/rcn/97420/factsheet/en), together with Horizon 2020 programs, e.g.,
ALGAE4A-B (http://www.algae4ab.eu/project.html) and VALUEMAG (https://www.valuemag.eu/),
have resulted in an increase in –omics data (i.e., genomics, transcriptomics, proteomics and
metabolomics data) available for microalgae, improving the possibility of finding new enzymes
from both marine and freshwater species [14]. Mogharabi and Faramarzi recently reported the isolation
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of some enzymes from algae and highlighted their potential as cell factories [15]. This review aims to
provide a summary of the current literature on microalgal enzymes with potential biotechnological
applications with a particular focus on enzymes involved in the production of high-value added lipids
and biodiesel, healthcare applications, and bioremediation.
2. Enzymes from Microalgae
2.1. Enzymes for High-Value Added Lipids and Biodiesel Production
Microalgae are known to accumulate large amounts of lipids [16], with triglycerides (TAGs)
and poly-unsaturated fatty acids (PUFA) being the most studied from a biotechnological application
standpoint, particularly for the production of biodiesel and nutraceuticals [9,16–18]. TAGs, esters
derived from glycerol and three chained fatty acids (FA) which are usually stored in cytosol-located
lipid droplets [19], can be used to produce biodiesel following acid- or base-catalyzed transesterification
reactions [20]. PUFAs, for their part, have well-proven beneficial health effects [21,22], especially Ω-3
fatty acids such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) (Figure 2).
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Figure 2. Examples of fatty acids of biotechnological interest. (a) Through various reactions of elongation
and formation of double C-C bonds, poly-unsaturated fatty acids (PUFA) can be synthetized, such as
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) with nutraceutical or food applications;
(b) Accumulation in triglycerides (TAGs) and biodiesel formation via chemical transesterification.
The most frequently studied enzyme involved in lipid synthesis is acyl-CoA diacylglycerol
acyltransferase (DGAT), involved in the final reaction of the TAG biosynthetic pathway [23,24]. Three
independent groups of enzymes, referred to as acyl-CoA diacylglycerol acyltransferases type 1, 2,
and 3 (DGATs 1-2-3), take part in the acyl-CoA-dependent formation of TAGs from its precursor
sn-1,2-diacylglycerol (DAG) [25]. The individual contribution of each DGAT isoenzyme to the fatty
acid profile of TAG differs between species [24,26].
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A gene encoding DGAT1 was initially discovered in the green alga Chlorella ellipsoidea by Guo et
al. [27], and an experiment involving overexpression of DGAT1 was subsequently performed in the
oleaginous microalgae Nannochloropsis oceanica [28]. The first DGAT2 sequence was obtained from
the green alga Ostreococcus tauri [29], and different studies involving overexpression of DGAT2 were
performed. In particular, DGAT2 overexpression led to an increase in TAG production in the diatoms
Phaeodactylum tricornutum [30] and Thalassiosira pseudonana [31], and in the oleaginous microalgae
Neochloris oleoabundans [32] and N. oceanica [33]. Different isoforms of DGAT2 (NoDGAT2A, 2C, 2D)
have successively been identified in N. oceanica and different combinations of either overexpression
or under-expression have been analyzed. These combinations gave different fatty acid-production
profiles, with some optimized for nutritional applications and others for biofuel purposes [34]. Even
if the green alga Chlamydomonas reinhardtii is considered a common biofuel feedstock, it showed no
clear trends following overexpression of different DGAT2 isoforms, with increased levels of TAG in
some reports [35], while levels were not increased in others [36]. Recently, Cui and coworkers [37]
characterized a dual-function wax ester synthase (WS)/DGAT enzyme in P. tricornutum, whose
overexpression led to an accumulation of both TAGs and wax esters. This was the first report of this
particular enzyme in a microalga, and a patent involving the enzyme was subsequently filed (Patent
Code: CN107299090A, 2017).
In addition to DGAT, other genes have been targeted in order to increase high-value
added lipid production, including glucose-6-phosphate dehydrogenase (G6PD), ∆6-desaturase,
6-phosphogluconate dehydrogenase (6PGD), glycerol-3-phosphate acyltransferase (GPAT1-GPAT2),
and acetyl-CoA synthetase 2 (ACS2). Overexpression of these enzymes resulted in increased lipid
contents [38–42]. In particular, two patents for desaturases have been filed. One covers a ∆6-desaturase
from Nannochloropsis spp., which converts linoleic acid to γ-linolenic acid (GLA) and α-linolenic acid
(ALA) to stearidnoic acid (Patent Code: CN101289659A, 2010). The other covers a Ω6-desaturase
from Arctic chlamydomonas sp. ArF0006, which converts oleic acid to linoleic acid (Patent Code:
KR101829048B1, 2018).
Other approaches to increase lipid production and/or alter lipid profiles via gene disruption have
been employed. Examples include the knock-out of a phospholipase A2 (PLA2) gene via CRISPR/Cas9
ribonucleoproteins in C. reinhardtii [43], microRNA silencing of the stearoyl-ACP desaturase (that forms
oleic acid via addition of a double-bond in a lipid chain [44]) in C. reinhardtii [45], and meganuclease
and TALE nuclease genome modification in P. tricornutum [46]. This last approach involved modifying
the expression of seven genes, potentially affecting the lipid content (UDP-glucose pyrophosphorylase,
glycerol-3-phosphate dehydrogenase, and enoyl-ACP reductase), the acyl chain length (long chain
acyl-CoA elongase and a putative palmitoyl-protein thioesterase), and the degree of fatty acid
saturation (Ω-3 fatty acid desaturase and ∆-12-fatty acid desaturase). In particular, a mutant for
UDP-glucose pyrophosphorylase showed a 45-fold increase in TAG accumulation under nitrogen
starvation conditions. Figure 3 provides an overview of the subcellular localization of metabolic
pathways and engineered enzymes in the aforementioned examples.
Finally, Sorigué and coworkers [47] reported, for the first time, the presence of a photoenzyme
named fatty acid photodecarboxylase (FAP) in Chlorella variabilis str microalgae. NC64A. FAP converts
fatty acids to hydrocarbons and may be useful in light-driven production of hydrocarbons. It is worth
mentioning that Misra et al. [48] have developed a database to catalogue the enzymes which have been
identified as being responsible for lipid synthesis from available microalgal genomes (e.g., C. reinhardtii,
P. tricornutum, Volvox carteri), called dEMBF (website: http://bbprof.immt.res.in/embf/). To date, the
database has collected 316 entries from 16 organisms, while providing different browsing options
(Search by: “Enzyme Classification”, “Organism”, and “Enzyme Class”) and different web-based tools
(NCBI’s Blast software integrated, sequence comparison, Motif prediction via the MEME software).
The enzymes discussed in this section are reported in Table 1.
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Table 1. Enzymes from Microalgae for Lipid and Biodiesel Production. Marine and freshwater ecological
strain sources are abbreviated as M or F, respectively. Algal classes of Bacillariophyceae, Chlorophyceae,
Trebouxiophyceae, Eustigmatophyceae, Mamiellophyceae, Coscinodiscophyceae, and Cyanidiophyceae are
abbreviated as BA, CH, TR, EU, MA, CO, and CY, respectively.
Ref. Enzymes Microalgae StrainSource
Microalgal
Class Main Results
[39] ∆6-Desaturase Phaeodactylumtricornutum M BA
Neutral lipid
production enhanced
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2.2. Enzymes for Healthc re Application
Enzymes for healthcare applications can include: (1) Enzymes used directly as “drugs”, or (2)
enzymes involved in the biosynthetic pathway of bioactive compounds (Figure 4). Regarding the first
group, the most studied enzyme is l-asparaginase. l-asparaginase is an l-asparagine amidohydrolase
enzyme used for the treatment of acute lymphoblastic leukemia, acute myeloid leukemia, and
non-Hodgkin’s ly phoma [49]. Its hydrolytic effect reduces asparagine availability for cancer cells
that are unable to synthesize l-asparaginase autonomously [50] l-asparaginase was historically first
discovered and then produced in bact ria (e.g., Escherichia coli, Erwinia aroideae, Bacillus cereus) [51–53].
However, in order to over ome some of the economical and safety limits as ociated with marketing
the nzyme [54,55], increased efforts began to focus on the identification and characterization of the
enzyme in microalgae strains.
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decarboxylase (PDS) and zeaxanthin epoxidase (ZEP). For the synthesis of oxylipins the studied
enzymes are lipoic acid hydrolases (LAH) and PLAT (Polycystin-1, Lipoxygenase, Alpha-Toxin)/LH2
(Lipoxygenase homology). An example of molecules and their roles for each pathway is also outlined.
Paul [56] first purified an l-asparaginase in Chlamidomonas spp. with limited anticancer activity, and
tested it in an in vivo anti-lymphoma assay. Ebrahiminezhad and coworkers screened 40 microalgal
isolates via activity assays and reported o Chlorella vulgaris as a novel potential feeds ock for
l-asparaginas productio [57].
Reg rding enzymat c pathways involved in the synthesis of bioactive compounds, many stud es
have focused on polyketide synthases (PKS) and nonribosomal peptide synthetases (NRPS). PKS
produce polyketides, while NRPS produce nonribosomal peptides. Both classes of secondar
metabolites are formed by sequential reactions oper ted by these “ egasynthase” enzymes [58,59].
olyketi es and nonribosomal p ptides have been repo ted t h ve antipr dat r, allelopathic, anticancer,
and antifungal activities [58,60–62]. PKS can be multi- omain enzymes (Type I PKS), large enzyme
c mplexes (Type II), or homodimeric complexes (Typ III) [63]. Genes po entially encoding these
first two types’ of PKSs h ve been identified in several microalgae (e.g., Amphidinium carterae,
Azadinium spinosum, Gambierdiscus spp., Karenia b evis [64–67]). Similarly, NRPSs have a modular
organization imilar to type I PKSs, and genes potentially encoding NRPSs have been found in
different micro lgae [68]. Moreover, metabolites that are likely to derive from hybrid NRPS/PKS gene
clusters have been reported from Karenia brevis [69]. However, to our knowl dge, th re are o studies
reporting the direct correlation of a PKS or NRPS gene from a microalga with the pro uction f a
bioactive compound.
Other microalgal enzymes which have been widely studied are those involved in the synthesis of
compounds wit nutraceutical and c smec utical applications, such as those involved in carotenoid
synthesis (e.g., astaxanthin, β-carotene, lutein, an canthaxanthin). Carotenoi s are isoprenoid
pigments, which have many cellular protective effects, such as ntioxidant effects ccurring via the
chemical que c ing of O2 and other reactive xygen sp cies [70–72]. Their antioxidant properties
can potentially protect humans from a compromised immune response, premature aging, arthriti ,
cardiovascul r diseas s, and/or certain cancers [72]. Among microalgae, the most studied for the
i dustri l production of carotenoids are the halophile mic alg Dunaliella salina and th green alga
Haematococcus pluvialis, which naturally produce high amounts of carotenoids [73]. Moreover, D.
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salina is a particularly versatile feedstock, and many researchers have focused on obtaining maximum
carotenoid yields without impeding its growth [74–76]. In addition, D. salina has been successfully
transformed via different approaches, such as microparticle bombardment [77] or via Agrobacterium
tumefaciens [78], increasing the feasibility of its use for biotechnological applications.
The most studied enzymes involved in carotenoid synthesis are: β-carotene oxygenase,
lycopene-β-cyclase, phytoene synthase, phytoene desaturase, β-carotene hydroxylase, and zeaxanthin
epoxidase [79]. In order to improve the production of carotenoids, different metabolic engineering
approaches have been employed. The initial method used was to induce random or site directed
mutations in an attempt to improve the activity of enzymes involved in the carotenoid metabolic
pathway. Increased production of carotenoids can also be achieved by changing culturing conditions or
by employing genetic modifications [79]. For example, mRNA levels of β-carotene oxygenase, involved
in the biosynthesis of ketocarotenoids [80], increased in Chlorella zofengiensis under combined nitrogen
starvation and high-light irradiation, and an increase canthaxanthin, zeaxanthin, and astaxanthin
was observed [81]. Couso et al. [82] reported an upregulation in lycopene-β-cyclase, which converts
lycopene to β-carotene [83] in C. reinhardtii under conditions of high light.
Regarding genetic modifications, Cordero [84] transformed the green microalga C. reinhardtii by
overexpressing a phytoene synthase (which converts geranylgeranyl pyrophosphate to phytoene)
isolated from Chlorella zofingiensis, resulting in a 2.0- and 2.2-fold increase in violaxanthin and lutein
production, respectively. A phytoene desaturase, which transforms the colorless phytoene into the
red-colored lycopene [85], was mutated in H. pluvialis by Steinbrenner and Sandmann [86], resulting in
the upregulation of the enzyme and an increase in astaxanthin production. Galarza and colleagues
expressed a nuclear phytoene desaturase in the plastidial genome of H. pluvialis, resulting in a 67%
higher astaxanthin accumulation when the strain was grown under stressful conditions [87]. The
insertion of a β-carotene hydroxylase from C. reinhardtii in Dunaliella salina resulted in a 3-fold increase
of violaxanthin and a 2-fold increase of zeaxanthin [78]. The inhibition of D. salina phytoene desaturase
using RNAi technology [88] resulted in an increase in phytoene content, but also a decrease in
photosynthetic efficiency and growth rate.
More modern methods which have been used include the use of CRISPR/Cas9 (clustered regularly
interspaced short palindromic repeats/CRISPR-associated protein 9) for precise and highly efficient
“knock-out” of key genes [89]. For example, Baek et al. have used CRISPR/Cas9 to knock-out the
zeaxanthin epoxidase (ZEP) gene in C. reinhardtii [90]. This enzyme is involved in the conversion of
zeaxantin to violaxantin [91], and with its knock-out they obtained a 47-fold increase in zeaxanthin
productivity. The current state-of-art involved in metabolic engineering for carotenoid production in
microalgae is further discussed in other reviews [72,92].
Other studies have focused on enzymes involved in the synthesis of oxylipins, which are secondary
metabolites that have previously been shown to have antipredator and anticancer activities [93–95].
Although oxylipin chemistry and putative biosynthetic pathways have been extensively studied
in both plants and microalgae [96–98], the related enzymes and genes have only recently been
identified and characterized in microalgae. Adelfi and coworkers have studied genes involved in
the biosynthesis of oxylipins in Pseudo-nitzchia multistriata and performed transcriptome analysis on
these genes in Pseudo-nitzchia arenysensis [99]. In diatoms, they characterized, for the first time, two
patatin-like lypolitic acid hydrolases (LAH1) involved in the release of the fatty acid precursors of
oxylipins and tested their galactolipase activity in vitro. Transcriptomic analysis also revealed three
of seven putative patatin genes (g9879, g2582, and g3354) in N. oceanica and demonstrated that they
were u-regulated under nitrogen-starvation conditions [100]. Similarly, Lauritano and coworkers
analyzed the transcriptome of the green alga Tetraselmis suecica and reported three PLAT (Polycystin-1,
Lipoxygenase, Alpha-Toxin)/LH2 (Lipoxygenase homology) domain transcripts [68]. The group also
performed in silico domain assessment and structure predictions. The enzymes discussed in this
section are described in Table 2.
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Table 2. Enzymes from Microalgae for Healthcare Applications. Marine, freshwater, and soil strain
sources are abbreviated as M, F, or S, respectively. Algal classes of Chlorophyceae, Trebouxiophyceae,
Bacillariophyceae, Dinophyceae, and Chlorodendrophyceae, are abbreviated as CH, TR, BA, DY, and
CR respectively.
Reference Enzymes Microalgae Strain Source MicroalgalClass Main Results
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2.3. Enzymes for Bioremediation
Bioremediation is the use of microorganisms and their enzymes for the degradation and/or
transformation of toxic pollutants into less dangerous metabolites/moieties. The potential, which
microalgae possess to proliferate in environments that are rich in nutrients (e.g., eutrophic environments)
and to biosequestrate heavy metal ions, makes them ideal candidate organisms for bioremediation
strategies [101,102]. The optimal goal in this area is to combine bioremediation activities with the
possibility of extracting lipids and other high-value added compounds from the biomass that is
produced [103–106] in order to reduce overall costs and to recycle materials. In this section, the focus
will be on enzymatic bioremediation, which is a novel approach involving the direct use of purified
or partially purified enzymes from microorganisms, and in this case, from microalgae, in order to
detoxify a specific toxicant/pollutant [107]. This method has recently started to demonstrate promising
results through the use of bacterial enzymes [108,109]. Examples are the use of enzymes for the
bioremediation of industrial waste and, in particular, the recent use of chromate reductases found in
chromium resistant bacteria, known to detoxify the highly toxic chromium Cr(VI) to the less-toxic
Cr(III) [110].
In microalgae, a recent study focused on Cr(VI) reduction involving C. vulgaris [111]. This activity
was suggested to involve both a biological route, through the putative enzyme chromium reductase,
and a nonbiological route: Using the scavenger molecule glutathione (GSH). With respect to chromium
removal, several strains of microalgae have been reported to be capable of achieving Cr(IV) removal
from water bodies, including Scenedesmus and Chlorella species [112–114]. In the aforementioned
transcriptome study on the green algae Tetraselmis suecica, a transcript for a putative nitrilase was
reported [68]. Given that nitrilases are enzymes that catalyze the hydrolysis of nitriles to carboxylic
acids and ammonia [115] and that this enzyme has recently been used for cyanide bioremediation
in wastewaters [116], this nitrilase in T. suecica may prove to be useful in the treatment of cyanide
contaminated water bodies.
Other enzymes have been reported to be overexpressed in microalgae when they are exposed
to contaminants, but it is not clear whether or not they are directly involved in their degradation
or whether they are produced as a stress defensive response in the cell in order to help balance
cellular homeostasis (e.g., to detoxify reactive oxygen/nitrogen species produced after exposure to
contaminants). Examples of these enzymes include peroxidases (Px), superoxide dismutase (SOD),
catalase (CAT), and glutathione reductase (GR). SOD, Px, and CAT typically function in helping
detoxify the cell from oxygen reactive species [117,118], while GR replenishes bioavailable glutathione,
catalyzing the reduction of glutathione disulfide (GSSG) to the sulfhydryl form (GSH) [119]. Regarding
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the detoxification of reactive nitrogen species, the most studied enzymes in microalgae are the nitrate
and nitrite reductases. The first enzyme reduces nitrate (NO3−) to nitrite (NO2−), while the second
subsequently reduces nitrite to ammonia (NH4+). NH4+ is then assimilated into amino acids via the
glutamine synthetase/glutamine-2-oxoglutarate amino-transferase cycle [120] (Figure 5).
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Table 3. Enzymes from Microalgae with utility in Bioremediation applications Marine, freshwater, and
lichenic strain sources are abbreviated as M, F, and L respectively. Algal classes of Trebouxiophyceae,
Chlorodendrophyceae, Chlorophyceae, and Bacillariophyceae are abbreviated as TR, CR, CH, and
BA, respectively.
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3. Conclusions and Future Perspectives
Among aquatic organisms that have recently received attention as potential sources of industrially
relevant enzymes [125,126], microalgae, in particular, stand out as a new sustainable and ecofriendly
source of biological products (e.g., lipids, carotenoids, oxylipins, and polyketides). This review
summarized the available information on enzymes from microalgae with possible biotechnological
applications, with a particular focus on value-added lipid production, together with healthcare and
bioremediation applications.
The promise of microalgae as potential sources of novel enzymes of interest is reflected in the
abundance of recent reports in the literature in this area. However, the biotechnological exploitation of
their enzymes in comparison to other potential sources has only become more feasible quite recently,
primarily due to the implementation of novel isolation and culturing procedures, together with an
increase in the availability of -omics data. This data has facilitated the use of a broader array of
approaches, such as site-specific mutagenesis, bioinformatics-based searches for genes of interest,
and/or the use of genome editing tools (e.g., CRISPR/Cas9 and TILLING), resulting in promising
results particularly with respect to high-performance lipid [46] and carotenoid [89] production in
different microalgae.
The majority of studies to date have focused on enzymes involved in pathways for lipid synthesis in
order to increase their total production or to direct cellular production to lipid classes with applications
as nutraceuticals, cosmeceuticals, or as a feedstock for biodiesel production. For this reason, several
recent studies have focused on the improvement of lipid production in oleaginous microalgae. In
addition, algal biomass is often used for the extraction of both lipids and other value-added products,
such as pigments and proteins, in order to maximize the production of useful products such as these at
the lowest possible cost [127–129].
Future approaches to maximize the enzymatic potential of microalgae are likely to focus on three
different approaches: (1) The use of ever-increasing amounts of available -omics data to optimize
microalgal strains for the production of valuable products, through the overexpression of one or more
enzymes through the use of genome editing tools; (2) identification and subsequent characterization
of metabolic pathways involved in the production of specific bioactives (e.g., polyketides), many of
which are still poorly characterized; (3) the search for genes with direct biotechnological applications
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(e.g., l-asparaginase, chromate reductase, nitrilase) in microalgal genomes and transcriptomes datasets.
A common element in all three approaches is the potential use of next generation sequencing based
approaches (NGS) [130], the price of which is declining rapidly [131].
The feasibility of employing any of the aforementioned three approaches will be directly influenced
by progress in methods to decrease the costs of growth and genetic manipulation of microalgae. The
ultimate aim would be to mimic what has happened in the area of bacterial enzymology, where robust
pipelines for enzyme discovery have been established. If this could be achieved, then it is clear that
microalgae are likely to meet our expectations as a promising source of novel enzymes with utility in a
variety of different biotechnological applications.
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